证券代码：601969 证券简称：海南矿业 公告编号：2025-086 海南矿业股份有限公司 一、回购股份的基本情况 海南矿业股份有限公司（以下简称"公司"）于 2025 年 3 月 12 日召开 2025 年第二次临时股东大会，审议通过了《关于以集中竞价交易方式回购股份方案的 议案》，同意公司以自有资金和股票回购专项贷款通过集中竞价交易方式回购公司 发行的人民币普通股（A 股）股票，回购价格上限为人民币 10.12 元/股，回购资 金总额不低于人民币 7,500 万元（含）且不超过人民币 15,000 万元（含）。回购 期限为自公司 2025 年第二次临时股东大会审议通过回购方案之日起不超过 12 个 月，本次回购股份价格上限不超过人民币 10.04 元/股（含）。 具体内容详见公司于 2025 年 3 月 15 日披露的《关于以集中竞价交易方式回 购股份的回购报告书》（公告编号：2025-037）。 二、实施回购股份的进展情况 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》等相关规定，上市公司应当在每个月的前 3 个交易日内公告截 至上月末的回购进展情况，现将公司 ...

证券代码：601969 证券简称：海南矿业 公告编号：2025-087 海南矿业股份有限公司 关于控股股东股份质押公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 截至本公告日，海南矿业股份有限公司（以下简称"公司"）控股股东上海 复星高科技（集团）有限公司（以下简称"复星高科"）持有公司股份 949,056,507 股，占公司股份总数的 47.48%；累计质押公司股份（含本次） 700,000,000 股，占其所持公司股份数的 73.76%，占公司股份总数的 35.02%。 一、上市公司股份质押 单位：股 股东名称 是否为 控股股 东 本次质押股 数 是否为 限售股 是否 补充 质押 质押起 始日 质押到期 日 质权人 占其所 持股份 比例 （%） 占公司 总股本 比例 （%） 质押融 资资金 用途 复星高科 是 350,000,000 否 否 2025 年 7 月 1 日 2027 年 6 月 12 日 华润深 国投 36.88 17.51 偿还债 务 二、上市公司控股股东股份质押情况 截至本公告披露日 ...

证券代码：601969 证券简称：海南矿业 海南矿业股份有限公司 2025 年第二季度投资者关系活动事项纪要 编号：2025-002 海南矿业股份有限公司（以下简称"公司"）2025 年第二季度与投资者在 信息披露范围内互动交流情况主要为: 召开 2 场网上业绩说明会；与投资者进行 "一对一"或"一对多"沟通交流及参加券商策略会等共 14 次，主要交流机构 包括新加坡政府投资公司、南方基金、汇华理财、富国基金等；接待个人投资者 来访 1 次；接听投资者来电 59 次；在上证 e 互动"问答"栏目回复投资者提问 12 次；投资者关系微信公众号"海南矿业投资者关系"发布公司动态 35 条；投 资者关系视频号"海南矿业投资者关系"发布视频 5 条。 投资者主要关注八角场气田最新产量水平、八角场气田天然气售价和成本、 氢氧化锂项目进展、油气业务的生产经营模式等方面。 | 序号 | 沟通方式 | 次数 | | --- | --- | --- | | 1 | 网上业绩说明会 | 2 | | 2 | "一对一"或"一对多"沟通交流及策略会 | 14 | | 3 | 接待个人投资者来访 | 1 | | 4 | 接听投资者咨询 ...

Report Summary 1. Industry Investment Rating - Not provided in the content 2. Core View - The spot trading of lithium carbonate is sluggish, and it is operating in a weak and volatile manner. The trend strength of lithium carbonate is -1, indicating a bearish view [1][3] 3. Summary by Relevant Catalogs Fundamental Tracking - **Futures Contracts**: For the 2507 contract, the closing price is 62,980, the volume is 955, and the open interest is 10,845. For the 2509 contract, the closing price is 62,780, the volume is 398,387, and the open interest is 326,676 [1] - **Basis and Other Data**: The basis between the spot and 2507 contract is -1,680, and between the spot and 2509 contract is -1,480. The difference between battery - grade and industrial - grade lithium carbonate is 1,600 [1] - **Raw Materials and Lithium Salts**: The price of spodumene concentrate (6%, CIF China) is 625, and battery - grade lithium carbonate is 61,300. Other lithium salts and related products also have corresponding price data [1] Macro and Industry News - SMM's battery - grade lithium carbonate index price is 61,332 yuan/ton, down 61 yuan/ton from the previous working day. Battery - grade and industrial - grade lithium carbonate prices remained flat compared to the previous working day [1] - Hainan Mining signed a spodumene off - take agreement with LMLB. Starting from January 1, 2026, LMLB will sell all the spodumene produced in the first phase of the Bugoni lithium mine project to Hainan Mining, which is an important step in its industrial layout [3]

Battery - Foton Motor has begun mass application of semi-solid batteries in its self-developed 24V starting lithium batteries, which are installed in its electric light trucks [2] - Beijing Chunzhi New Energy Technology Co., Ltd. launched a pilot project for electric bicycle battery swapping using all-solid-state batteries, marking the transition of its products from laboratory to commercial application [6] Materials - Zhongke Chuncui Technology successfully completed a Pre-A round of financing, which will be used to optimize new extraction agents for strategic metals and establish production projects for battery-grade lithium chloride and lithium dihydrogen phosphate [8] - Enjie Co., Ltd. announced that its subsidiary has begun mass shipments of high-purity lithium sulfide products, while another subsidiary is advancing the construction of a pilot project for solid-state electrolyte with a capacity of thousands of tons [10] - Hainan Mining signed a lithium spodumene off-take agreement with its subsidiary, ensuring that all spodumene produced from the Bukuni lithium mine project will be sold to Hainan Mining starting January 1, 2026 [11] - Yunnan Zhongke Xingcheng Graphite Co., Ltd. is set to construct a project with an annual production capacity of 100,000 tons of lithium battery anode materials, with a total investment of 2.5 billion yuan [13]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

Meeting Overview - The fifth meeting of the board of directors of Hainan Mining Co., Ltd. was held on June 30, 2025, with all 11 directors present, complying with relevant laws and regulations [1]. Loan Approval - The board approved a proposal for Roc Oil Company Pty Limited, a wholly-owned subsidiary, to apply for a loan of 600 million RMB from China Merchants Bank and up to 200 million USD from a syndicate of banks, including Standard Chartered Bank, Hang Seng Bank, and Qatar National Bank [1][2]. - The loans will be used to pay for the acquisition of shares in Tethys Oil AB and for capital expenditures and operating funds for new projects [1]. Collateral Details - The club loan will be secured by 100% equity of Roc Oil Company Pty Limited and its seven wholly-owned subsidiaries, with additional collateral if the loan exceeds 150 million USD [2]. - The total assets pledged for the equity pledge and collateral exceed 30% of the company's most recent audited total assets [3]. Financial Health - The company and Roc Oil are reported to have stable operations and good cash flow, indicating strong debt repayment capability without significant risk of default [3]. Board Committee Update - The board approved the addition of Ms. Zhou Hongxia to the Strategic and Sustainable Development Committee, Nomination Committee, and Compensation and Assessment Committee, effective immediately [3].

关于回购注销部分限制性股票减少注册资本 暨通知债权人的公告 证券代码：601969 证券简称：海南矿业 公告编号：2025-084 海南矿业股份有限公司 债权申报具体方式如下： 1、申报时间：2025年7月1日起至2025年8月14日期间的每个工作日 8:30-11:00；14:00至17:00 2、申报地址：海南省澄迈县老城镇沃克公园8801栋 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、通知债权人的原由 海南矿业股份有限公司（以下简称"公司"）于2025年5月29日召开第五届董 事会第三十二次会议，审议通过了《关于调整2022年限制性股票激励计划限制性 股票回购价格的议案》、《关于2022年限制性股票激励计划回购注销部分限制性股 票的议案》等，并于2025年6月30日召开2025年第二次临时股东大会，审议通过 了《关于2022年限制性股票激励计划回购注销部分限制性股票的议案》。因存在 部分离职、病休离岗、退居二线、离岗待退、个人绩效考核未完全达标等情况， 公司同意对上述人员已获授但未解除限售的合计543,987股限 ...

海南矿业股份有限公司 关于与控股子公司签订锂辉石包销协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为打造锂资源一体化产业链，海南矿业股份有限公司（以下简称"公司"） 近日与控股子公司 Le Minesde Lithium de Bougouni SA(以下简称"LMLB") 签订了锂辉石包销协议（以下简称"包销协议"）。LMLB 系公司控股子公司 Kodal Mining UK 之全资子公司，其名下持有布谷尼锂矿采矿权。布谷尼锂矿 项目一期建有 140 万吨/年选矿生产线，预计可生产品位为 5.5%以上的锂精矿 10-12 万吨/年。 根据包销协议，自 LMLB 获得产品出口证起四年内，其在布谷尼锂矿项目 一期下生产的锂辉石均出售给公司（含合并报表范围内子公司）。本次包销 协议的单价以双方协定的公式价格为准，并采用底价机制；自 2026 年 1 月 1 日起每年设定年度底价，如果公式算出的价格低于年度底价，实际支付价以 底价为准。 本次包销协议的签署是公司持续落地锂矿采选和锂盐加工业务一体化产 业布局的重要举措， ...

上海市锦天城律师事务所 关于海南矿业股份有限公司 2025 年第三次临时股东大会之 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于海南矿业股份有限公司 2025 年第三次临时股东大会之法律意见书 致：海南矿业股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受海南矿业股份有限公司 （以下简称"公司"）委托，就公司召开 2025 年第三次临时股东大会（以下简称 "本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公 司法》"）《上市公司股东会规则》等法律、法规和规范性文件以及《海南矿业 股份有限公司章程》（以下简称"《公司章程》"）的有关规定，出具本法律意 见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的相关事 项进行了必要的核查和验证，核查 ...